# MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)

> **NCT00157729** · PHASE2 · COMPLETED · sponsor: **Medicure** · enrollment: 160 (—)

## Conditions studied

- Diabetes Mellitus Type 2
- Hypertension
- Metabolic Syndrome

## Interventions

- **DRUG:** pyridoxal-5'-phosphate with and without ACE inhibitor

## Key facts

- **NCT ID:** NCT00157729
- **Lead sponsor:** Medicure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 160 (—)
- **Last updated:** 2006-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157729, "MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00157729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*